References
- Steffy K, et al. Genetic regulation of human immunodeficiency virus. Microbiol Rev 1991; 55(2):193-205; PMID:1886517
- Guenzel CA, Hérate C, Benichou S. HIV-1 Vpr—a still “enigmatic multitasker”. Front Microbiol 2014; 5:127; PMID:24744753; http://dx.doi.org/10.3389/fmicb.2014.00127
- Heaton RK, Clifford DB, Franklin DR, WOods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 2010; 75(23):2087-96; PMID:21135382; http://dx.doi.org/10.1212/WNL.0b013e318200d727
- Grovit-Ferbas K, Harris-White ME. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol Res 2010; 48(1-3):40-58; PMID:20725864; http://dx.doi.org/10.1007/s12026-010-8166-x
- Chambers JW, Maguire TG, Alwine JC. Glutamine metabolism is essential for human cytomegalovirus infection. J Virol 2010; 84(4):1867-73; PMID:19939921; http://dx.doi.org/10.1128/JVI.02123-09
- Datta P, et al. Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr. Cell Cycle 2016; 15(17):2288-98; PMID:27245560; http://dx.doi.org/10.1080/15384101.2016.1190054
- Erdman N, Tian C, Huang Y, Zhao J, Herek S, Curthoys N, Zhang J. In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. J Neurochem 2009; 109: 551-61; PMID:19222703; http://dx.doi.org/10.1111/j.1471-4159.2009.05989.x